Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease

ClinicalTrials.gov ID: NCT00250679

Public ClinicalTrials.gov record NCT00250679. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 5:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter, Double-Blind, Double-Dummy, Randomized, Active-Controlled, Parallel Group Long-Term Safety Study of 15 μg and 25 μg Arformoterol Tartrate Inhalation Solution BID in Subjects With Chronic Obstructive Pulmonary Disease

Study identification

NCT ID
NCT00250679
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
443 participants

Conditions and interventions

Interventions

  • Arformoterol tartrate inhalation solution Drug
  • Arformoterol 25 ųg BID Drug
  • Formoterol 12 ųg BID Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
35 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2005
Primary completion
Sep 30, 2007
Completion
Sep 30, 2007
Last update posted
Jun 3, 2012

2005 – 2007

United States locations

U.S. sites
60
U.S. states
26
U.S. cities
59
Facility City State ZIP Site status
Not listed Birmingham Alabama
Not listed Jasper Alabama
Not listed Mobile Alabama
Not listed Little Rock Arkansas
Not listed Carmichael California
Not listed Fullerton California
Not listed Long Beach California
Not listed Paramount California
Not listed Rancho Mirage California
Not listed San Diego California
Not listed Walnut Creek California
Not listed Denver Colorado
Not listed Hartford Connecticut
Not listed Bay Pines Florida 33744
Not listed Brandon Florida
Not listed Gainesville Florida 32605
Not listed Panama City Florida
Not listed Tampa Florida
Not listed Atlanta Georgia 30309
Not listed Marietta Georgia
Not listed Normal Illinois
Not listed Evansville Indiana
Not listed Topeka Kansas
Not listed East Slidell Louisiana
Not listed Lafayette Louisiana
Not listed Metairie Louisiana
Not listed Sunset Louisiana
Not listed Baltimore Maryland
Not listed Chester Maryland
Not listed Wheaton Maryland
Not listed Ann Arbor Michigan
Not listed Saint Charles Missouri
Not listed St Louis Missouri 63117
Not listed St Louis Missouri
Not listed Albuquerque New Mexico
Not listed Chapel Hill North Carolina
Not listed Charlotte North Carolina
Not listed Statesville North Carolina 28625
Not listed Wilmington North Carolina
Not listed Winston-Salem North Carolina
Not listed Cincinnati Ohio
Not listed Lake Oswego Oregon
Not listed Medford Oregon 97504
Not listed Pittsburgh Pennsylvania
Not listed Swarthmore Pennsylvania
Not listed East Providence Rhode Island
Not listed Charleston South Carolina
Not listed Columbia South Carolina
Not listed Simpsonville South Carolina
Not listed Spartanburg South Carolina
Not listed Union South Carolina 29379
Not listed Knoxville Tennessee
Not listed Houston Texas
Not listed Katy Texas
Not listed San Antonio Texas
Not listed Danville Virginia
Not listed Richmond Virginia
Not listed Spokane Washington
Not listed Tacoma Washington
Not listed Morgantown West Virginia

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00250679, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 3, 2012 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00250679 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →